Cerus Corp. (CERS)
2.41
-0.15
(-5.86%)
USD |
NASDAQ |
Feb 20, 16:00
2.42
+0.01
(+0.41%)
After-Hours: 20:00
Cerus EPS Diluted (Quarterly) : -0.0001 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0305 |
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.02M |
| Revenue (Quarterly) | 52.70M |
| Total Expenses (Quarterly) | 52.72M |
| Enterprise Value | 483.35M |
| Gross Profit Margin (Quarterly) | 53.40% |
| Profit Margin (Quarterly) | -0.04% |
| Earnings Yield | -3.51% |
| Normalized Earnings Yield | -3.519 |